The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...

Meta Pharmaceuticals' core product, MiniTing, features a unique hook design and tensile strength over 20% higher than competing products, improving usability for medical personnel, providing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the trades showed up on ...

Looking ahead, revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.

It is a core set of values, systems and processes that help govern every decision a company makes. There is no right way or wrong way for companies to approach that, but they have to recognize ...

Want to create a more authentic personal brand? Filter the questions through your core values and you’ll have a more precise sense of the answer and, likely, be happier with your choices in the ...

For example, Core i5 processors from 2008 have the same brand name as Core i5 processors from 2023. This won’t be a problem if you’re buying new or refurbished from a big retailer. But if you’re ...

Investing.com – Israel stocks were higher after the close on Wednesday, as gains in the Insurance, Oil & Gas and Financials sectors led shares higher. At the close in Tel Aviv,... Investing.com ...

Shares of NYSE TEVA opened at $17.81 on Thursday. Teva Pharmaceutical Industries has a 12 month low of $11.62 and a 12 month high of $22.80. The company has a market cap of $20.17 billion, a P/E ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...